Development strategy is a critical driver of biopharma R&D pipeline performance. By integrating scientific, manufacturing, analytical, regulatory, and technology transfer decisions...
Clinical trials can no longer treat recruitment, decentralized delivery and real-time data collection as separate workstreams. Dr. Avi Kulkarni explains why sponsors...
Agilent Technologies Inc. announced it has entered into a definitive agreement to acquire Proscia®, a provider of digital pathology software for clinical and life-sciences customers, ...
Sandoz is investing approximately US$300 million in a new biosimilar drug substance manufacturing facility in Ljubljana, Slovenia. The investment will expand the company’s...
Ambry Genetics, a leader in clinical genomic testing and a wholly owned subsidiary of Tempus AI, Inc., today announced the launch of GenomeNext™ and GenomeReveal™...
Researchers at the University of Toronto have developed an engineered transfer RNA (tRNA) approach that could support the treatment of multiple genetic diseases caused...
FDA expedited programs sit at the center of a persistent regulatory tension: patients with serious diseases need earlier access to promising therapies, but earlier access often...
